Zebra Biologics is a biopharmaceutical company. It develops agonist antibody drugs and other protein-based agonist therapeutics. The company offers a platform that allows cellular function-based screening for the discovery of human therapeutic biologics from DNA-encoded combinatorial libraries of human antibodies and peptides. ​